COVID-19 antibodies persist, reduce reinfection risk for up to six months, study finds

ScienceDaily
Sep 14, 2021, 6:48 pm556 ptsHot
Most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months, a new study found. The antibodies' ability to neutralize COVID-19 did not differ significantly from the first visit, which occurred three months after infection, to the second…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

Wetlands loss has increased residential flood insurance claim payments by $10 billion across the US, study finds 129

New York sues over Interior Dept.’s $1B bribe to an oil company stop wind power 127

Descendants of people pushed out for DRC national park lead forest conservation efforts 125

Orange EV scores record, 600 unit order as demand for electric semi trucks soars 120

Environmental engineers reshape understanding of airborne pollution particles 117

Heat Is a Growing Threat to the Hajj Pilgrimage—Even in Spring 117

Biden’s clean drinking water plan is being rebranded as MAHA 114

Trump budget could eliminate chemical safety group 113

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.